GSK’s Phase II, Single-Arm Trial For Jemperli In Rectal Cancer Gets Panel Nod

 
• By Sue Sutter
  
Plane taking off
GSK's plan for accelerated approval based on single-arm studies was cleared for takeoff by ODAC. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers